Jumbotron-image_large

Webcasts

2019 Webcasts

Changing Landscape of Therapies for Urothelial Carcinoma and Non-Muscle-Invasive Bladder Cancer with PD-1/PD-L1 Inhibitors, ADC and Recombinant Adenovirus Mediated Interferon-α2b

Released on 6/24/19
Expires on 6/24/20

Evolving Landscape of Treatment for Hepatocellular Carcinoma with Multi-Targeted Tyrosine Kinase Inhibitors and Immunotherapy

Released on 6/24/19
Expires on 6/24/20

Changing Landscape of Targeted and Immunotherapies for Genitourinary Cancers

Released on 6/12/19
Expires on 6/12/20

Changing Treatment Landscape of Metastatic Head and Neck Squamous Cell Carcinoma with Anti-PD-1/PD-L1 Agents

Released on 6/10/19
Expires on 6/10/20

New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia

Released on 5/13/19
Expires on 5/13/20

Optimizing Outcomes in Patients with Malignant Melanoma Treated with Targeted Agents, Checkpoint Inhibitors and Oncolytic Viral Therapiesr

Released on 12/30/18
Expires on 12/30/19

Emerging Novel PI3K Inhibitors, Anti-CD20 mAb and Combination Therapy Options for Follicular Lymphoma

Released on 12/30/18
Expires on 12/30/19

Changing Landscape of Treatment Strategies of TKI Interruptions, Discontinuations and Switching in Patients with Chronic Myeloid Leukemia

Released on 12/30/18
Expires on 12/30/19

Update on Treatment Options for Acute Lymphoblastic Leukemia with An Emphasis on CD19, CD22 Monoclonal Antibodies and Anti-CD19 CAR T-cell Therapy

Released on 12/30/18
Expires on 12/30/19

View All Enduring Webcast Programs